Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium

NCT02709031 is registered in ClinicalTrials.gov with Navitas Pharma as lead sponsor.

NCT NCT02709031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02709031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium
Lead sponsor
Navitas Pharma
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2022
Completion date
September 30, 2024
Enrollment
24 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension, diabetes, hypokalemia, hyponatremia